Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
CFX.TO Quote, Financials, Valuation and Earnings
Last price:
$0.66
Seasonality move
:
2.45%
Day range:
$0.63 - $0.67
52-week range:
$0.33 - $0.82
Dividend yield:
0%
P/E ratio:
10.06x
P/S ratio:
0.06x
P/B ratio:
0.26x
Volume:
177.5K
Avg. volume:
77.3K
1-year change:
-17.5%
Market cap:
$43.1M
Revenue:
$798.6M
EPS (TTM):
-$0.16
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $990.5M | $1.1B | $1.1B | $875.5M | $798.6M | |
| Revenue Growth (YoY) | -8.95% | 15.59% | -5.18% | -19.35% | -8.78% | |
| Cost of Revenues | $1B | $1.1B | $1.1B | $972.2M | $788.1M | |
| Gross Profit | -$45.3M | $57.7M | -$19.5M | -$96.7M | $10.5M | |
| Gross Profit Margin | -4.57% | 5.04% | -1.8% | -11.05% | 1.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.7M | $28.3M | $29M | $27.6M | $26M | |
| Other Inc / (Exp) | $30.7M | -$85.5M | -$52.5M | $8.2M | -$192M | |
| Operating Expenses | $23.8M | $28.3M | $29M | $27.6M | $26M | |
| Operating Income | -$69.1M | $29.4M | -$48.5M | -$124.3M | -$15.5M | |
| Net Interest Expenses | $3.5M | $3.2M | $5.6M | $11.6M | $13.7M | |
| EBT. Incl. Unusual Items | -$30.6M | -$61M | -$108.3M | -$132.5M | -$221.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$8.2M | -$16.6M | -$29.2M | -$36.4M | -$59.9M | |
| Net Income to Company | -$22.4M | -$44.4M | -$79.1M | -$96.1M | -$161.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$22.4M | -$44.4M | -$79.1M | -$96.1M | -$161.9M | |
| Basic EPS (Cont. Ops) | -$0.34 | -$0.68 | -$1.21 | -$1.47 | -$2.48 | |
| Diluted EPS (Cont. Ops) | -$0.34 | -$0.68 | -$1.21 | -$1.47 | -$2.48 | |
| Weighted Average Basic Share | $65.2M | $65.2M | $65.2M | $65.2M | $65.2M | |
| Weighted Average Diluted Share | $65.2M | $65.2M | $65.2M | $65.2M | $65.2M | |
| EBITDA | $13.2M | $116.8M | $49.3M | -$39.3M | $43.3M | |
| EBIT | -$69.1M | $29.4M | -$48.5M | -$124.3M | -$15.5M | |
| Revenue (Reported) | $990.5M | $1.1B | $1.1B | $875.5M | $798.6M | |
| Operating Income (Reported) | -$69.1M | $29.4M | -$48.5M | -$124.3M | -$15.5M | |
| Operating Income (Adjusted) | -$69.1M | $29.4M | -$48.5M | -$124.3M | -$15.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $298.9M | $308.3M | $188.8M | $193.2M | $164.6M | |
| Revenue Growth (YoY) | 32.02% | 3.15% | -38.76% | 2.33% | -14.8% | |
| Cost of Revenues | $276M | $282M | $231.6M | $184.9M | $176M | |
| Gross Profit | $22.9M | $26.3M | -$42.8M | $8.3M | -$11.4M | |
| Gross Profit Margin | 7.66% | 8.53% | -22.67% | 4.3% | -6.93% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.1M | $7.1M | $6.5M | $6.6M | $4.6M | |
| Other Inc / (Exp) | $1.8M | $3.8M | $3.2M | -$211.7M | -- | |
| Operating Expenses | $7.1M | $7.1M | $6.5M | $6.6M | $4.6M | |
| Operating Income | $15.8M | $19.2M | -$49.3M | $1.7M | -$16M | |
| Net Interest Expenses | $1.1M | $2.1M | $3.3M | $3.6M | $2.8M | |
| EBT. Incl. Unusual Items | $16.5M | $22.3M | -$49.4M | -$213.6M | -$17.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.4M | $6M | -$13.7M | -$57.5M | -$4.7M | |
| Net Income to Company | $12.1M | $16.3M | -$35.7M | -$156.1M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.1M | $16.3M | -$35.7M | -$156.1M | -$12.4M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.25 | -$0.55 | -$2.39 | -$0.19 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.25 | -$0.55 | -$2.39 | -$0.19 | |
| Weighted Average Basic Share | $65.2M | $65.2M | $65.2M | $65.2M | $65.2M | |
| Weighted Average Diluted Share | $65.2M | $65.2M | $65.2M | $65.2M | $65.2M | |
| EBITDA | $37.8M | $46.7M | -$27.7M | $18.8M | -$7.2M | |
| EBIT | $15.8M | $19.2M | -$49.3M | $1.7M | -$16M | |
| Revenue (Reported) | $298.9M | $308.3M | $188.8M | $193.2M | $164.6M | |
| Operating Income (Reported) | $15.8M | $19.2M | -$49.3M | $1.7M | -$16M | |
| Operating Income (Adjusted) | $15.8M | $19.2M | -$49.3M | $1.7M | -$16M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $949.7M | $829.4M | $701.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.1B | $1.1B | $1.1B | $831.7M | $689.7M | |
| Gross Profit | $62.4M | -$27.4M | -$113.1M | -$2.3M | $12.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $27.2M | $28M | $29.7M | $26.5M | $18.5M | |
| Other Inc / (Exp) | $24.9M | -$91.2M | -$50.9M | -$194.8M | -- | |
| Operating Expenses | $27.3M | $28M | $29.7M | $26.5M | $18.5M | |
| Operating Income | $35.1M | -$55.4M | -$142.8M | -$28.8M | -$6.4M | |
| Net Interest Expenses | $4.7M | $6.2M | $12.2M | $15.1M | $11M | |
| EBT. Incl. Unusual Items | $63.7M | -$151.4M | -$209M | -$244.6M | -$14M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.2M | -$41M | -$56.3M | -$66.6M | -$3.8M | |
| Net Income to Company | $46.5M | -$110.4M | -$152.7M | -$178M | -$10.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $46.5M | -$110.4M | -$152.7M | -$178M | -$10.2M | |
| Basic EPS (Cont. Ops) | $0.71 | -$1.69 | -$2.34 | -$2.73 | -$0.16 | |
| Diluted EPS (Cont. Ops) | $0.71 | -$1.69 | -$2.34 | -$2.73 | -$0.16 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $121.9M | $38.6M | -$47.6M | $38M | $29.9M | |
| EBIT | $35.1M | -$55.4M | -$142.8M | -$28.8M | -$6.4M | |
| Revenue (Reported) | $1.1B | $1.1B | $949.7M | $829.4M | $701.8M | |
| Operating Income (Reported) | $35.1M | -$55.4M | -$142.8M | -$28.8M | -$6.4M | |
| Operating Income (Adjusted) | $35.1M | -$55.4M | -$142.8M | -$28.8M | -$6.4M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $817.5M | $681.6M | $635.5M | $538.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $810.3M | $769.7M | $629.2M | $535.6M | -- | |
| Gross Profit | $7.2M | -$88.1M | $6.3M | $3.1M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.4M | $21.1M | $20M | $13.6M | -- | |
| Other Inc / (Exp) | $3.7M | $5.3M | -$194.5M | -$800K | -- | |
| Operating Expenses | $20.4M | $21.1M | $20M | $13.6M | -- | |
| Operating Income | -$13.2M | -$109.2M | -$13.7M | -$10.5M | -- | |
| Net Interest Expenses | $4.7M | $9.6M | $11.5M | $8.2M | -- | |
| EBT. Incl. Unusual Items | -$12.8M | -$113.5M | -$225.6M | -$17.8M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.5M | -$30.6M | -$60.8M | -$4.7M | -- | |
| Net Income to Company | -$9.3M | -$82.9M | -$164.8M | -$13.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.3M | -$82.9M | -$164.8M | -$13.1M | -- | |
| Basic EPS (Cont. Ops) | -$0.14 | -$1.27 | -$2.53 | -$0.20 | -- | |
| Diluted EPS (Cont. Ops) | -$0.14 | -$1.27 | -$2.53 | -$0.20 | -- | |
| Weighted Average Basic Share | $195.7M | $195.7M | $195.7M | $195.7M | -- | |
| Weighted Average Diluted Share | $195.7M | $195.7M | $195.7M | $195.7M | -- | |
| EBITDA | $58.2M | -$40.4M | $36.9M | $17.6M | -- | |
| EBIT | -$13.2M | -$109.2M | -$13.7M | -$10.5M | -- | |
| Revenue (Reported) | $817.5M | $681.6M | $635.5M | $538.7M | -- | |
| Operating Income (Reported) | -$13.2M | -$109.2M | -$13.7M | -$10.5M | -- | |
| Operating Income (Adjusted) | -$13.2M | -$109.2M | -$13.7M | -$10.5M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.8M | $73.3M | $14.7M | $21.1M | $15.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $64.3M | $66.7M | $82.4M | $47.8M | $30.1M | |
| Inventory | $188.5M | $211.8M | $183.2M | $165.9M | $155.5M | |
| Prepaid Expenses | $18.6M | $10.8M | -- | -- | -- | |
| Other Current Assets | -- | -- | $26.6M | $10.2M | $7.6M | |
| Total Current Assets | $317.8M | $372.1M | $314.4M | $251.5M | $216.1M | |
| Property Plant And Equipment | $576M | $450.3M | $420M | $409.9M | $186.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $6.5M | $2.7M | $8.4M | $6.4M | $5.7M | |
| Total Assets | $943.9M | $862.4M | $787.4M | $739.9M | $452.9M | |
| Accounts Payable | $122.9M | $103.4M | $110.5M | $127.7M | $98.1M | |
| Accrued Expenses | $38.7M | $43.6M | $39.6M | $32M | $31.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1M | $800K | $900K | $800K | $700K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $162.6M | $150.9M | $166M | $267.5M | $228.2M | |
| Long-Term Debt | $51.5M | $52.1M | $51.9M | $1.4M | $1.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $411.4M | $367.4M | $360M | $402.8M | $276.9M | |
| Common Stock | $480.8M | $480.8M | $480.8M | $480.8M | $480.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $532.5M | $495M | $427.4M | $337.1M | $176M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $532.5M | $495M | $427.4M | $337.1M | $176M | |
| Total Liabilities and Equity | $943.9M | $862.4M | $787.4M | $739.9M | $452.9M | |
| Cash and Short Terms | $6.8M | $73.3M | $14.7M | $21.1M | $15.3M | |
| Total Debt | $52.5M | $52.9M | $52.8M | $2.2M | $1.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $55.7M | $6.5M | -- | $29.8M | $8.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $107.3M | $113.7M | $50.4M | $36.1M | $22.3M | |
| Inventory | $233.5M | $207.7M | $148.8M | $140.8M | $151.7M | |
| Prepaid Expenses | $14.7M | $25.2M | -- | -- | -- | |
| Other Current Assets | -- | -- | $15.3M | $12M | -- | |
| Total Current Assets | $417.3M | $365.4M | $221.2M | $227.2M | $202M | |
| Property Plant And Equipment | $575.1M | $492.3M | $420.9M | $196.4M | $179.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.9M | $6.6M | $7.5M | $6.2M | -- | |
| Total Assets | $995.3M | $864.3M | $649.6M | $470.6M | $432.8M | |
| Accounts Payable | $140.8M | $147.1M | $129.3M | $123.4M | $112.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $50M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1M | $1M | $600K | $1M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $226.3M | $180.7M | $220.4M | $248.5M | $220.9M | |
| Long-Term Debt | $2.1M | $51.8M | $2M | $1.4M | $1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $402.5M | $365.2M | $301.5M | $297.2M | $267.2M | |
| Common Stock | $480.8M | $480.8M | $480.8M | $480.8M | $480.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $592.8M | $499.1M | $348.1M | $173.4M | $165.6M | |
| Total Liabilities and Equity | $995.3M | $864.3M | $649.6M | $470.6M | $432.8M | |
| Cash and Short Terms | $55.7M | $6.5M | -- | $29.8M | $8.6M | |
| Total Debt | $53.1M | $52.8M | $2.6M | $2.4M | $1.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$22.4M | -$44.4M | -$79.1M | -$96.1M | -$161.9M | |
| Depreciation & Amoritzation | $82.3M | $87.4M | $97.8M | $85M | $58.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $6.8M | $1.6M | -$11.4M | $33.5M | $16.4M | |
| Change in Inventories | $5.2M | -$23.3M | $28.6M | $7.4M | $6.2M | |
| Cash From Operations | $92.6M | $145.7M | $39.5M | $24.9M | $45.7M | |
| Capital Expenditures | $73.3M | $78.7M | $112.6M | $60.5M | $50.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$72.8M | -$78.1M | -$112.2M | -$59.8M | -$41.9M | |
| Dividends Paid (Ex Special Dividend) | $4.1M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $15M | $92M | -- | |
| Long-Term Debt Repaid | -$900K | -$1.1M | -$900K | -$50.7M | -$9.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.4M | -$3.2M | -- | -- | -- | |
| Cash From Financing | -$19M | -$1.1M | $14.1M | $41.3M | -$9.6M | |
| Beginning Cash (CF) | $6.8M | $73.3M | $14.7M | $21.1M | $15.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $800K | $66.5M | -$58.6M | $6.4M | -$5.8M | |
| Ending Cash (CF) | $7.6M | $139.8M | -$43.9M | $27.5M | $9.5M | |
| Levered Free Cash Flow | $19.3M | $67M | -$73.1M | -$35.6M | -$5.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$101.1M | -$69.8M | -$13.2M | $2.9M | -- | |
| Depreciation & Amoritzation | $22.7M | $26.4M | $16.2M | $8.2M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $37.2M | $36.2M | $2.1M | $6.7M | -- | |
| Change in Inventories | $21.7M | $24.5M | -$20.9M | -$14.7M | -- | |
| Cash From Operations | $33.7M | $36.2M | $16.9M | -$8.7M | -- | |
| Capital Expenditures | $16M | $28M | $21.9M | $6.1M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.9M | -$27.8M | -$21.5M | -$5.6M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$200K | -$200K | -$200K | -$9.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.1M | -- | -- | -- | -- | |
| Cash From Financing | -$200K | -$200K | $25.7M | -$200K | -- | |
| Beginning Cash (CF) | $73.3M | $14.7M | $21.1M | $15.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.6M | $8.2M | $21.1M | -$14.5M | -- | |
| Ending Cash (CF) | $90.9M | $22.9M | $42.2M | $800K | -- | |
| Levered Free Cash Flow | $17.7M | $8.2M | -$5M | -$14.8M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $46.5M | -$110.4M | -$152.7M | -$178M | -$10.2M | |
| Depreciation & Amoritzation | $86.9M | $94.1M | $95.2M | $66.8M | $36.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$47.9M | -$10.4M | $67.6M | $11.8M | $17M | |
| Change in Inventories | -$34.4M | $25.8M | $52.8M | -- | -$11.5M | |
| Cash From Operations | $122.4M | $37M | $44.2M | $71.3M | $2.6M | |
| Capital Expenditures | $96.9M | $100.6M | $66.6M | $66.6M | $23.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$96.3M | -$100.3M | -$66.1M | -$57.8M | -$23.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | $12.8M | -$900K | -$50.7M | -$600K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.7M | -- | -- | -- | -- | |
| Cash From Financing | -$1.2M | $14.1M | $15.4M | $16.3M | -$700K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $24.9M | -$49.2M | -$6.5M | $29.8M | -$21.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $25.5M | -$63.6M | -$22.4M | $4.7M | -$21.2M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$79.1M | -$96.1M | -$161.9M | -$13.1M | -- | |
| Depreciation & Amoritzation | $97.8M | $85M | $58.8M | $28.1M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$11.4M | $33.5M | $16.4M | $10.3M | -- | |
| Change in Inventories | $28.6M | $7.4M | $6.2M | $3.2M | -- | |
| Cash From Operations | $39.5M | $24.9M | $45.7M | $11.3M | -- | |
| Capital Expenditures | $112.6M | $60.5M | $50.8M | $17.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$112.2M | -$59.8M | -$41.9M | -$17.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$900K | -$50.7M | -$9.6M | -$23.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.1M | $41.3M | -$9.6M | -$500K | -- | |
| Beginning Cash (CF) | $44.5M | $29.7M | $95.2M | $13.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$58.6M | $6.4M | -$5.8M | -$6.7M | -- | |
| Ending Cash (CF) | -$14.1M | $36.1M | $89.4M | $6.6M | -- | |
| Levered Free Cash Flow | -$73.1M | -$35.6M | -$5.1M | -$6.4M | -- | |
Get CFX.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CFX.TO
Sector
P/E ratio
10.06x
19.88x
PEG ratio
0.00x
-0.02x
P/B ratio
0.26x
1.85x
Price / LTM sales
0.06x
1.65x
Growth Metrics
CFX.TO
Sector
Revenue growth
-14.8%
2.4%
Earnings growth
92.06%
--
Revenue (5-year growth)
-6%
3.24%
Earnings forecast
-$0.26
$0.03
Profitability
CFX.TO
Sector
Profitability FY 2024
$10.5M
--
Return on invested capital
-3.85%
-9.18%
Return on assets
-2.29%
-10.59%
Return on equity
-5.84%
-9.79%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
4
Balance Sheet
CFX.TO
Sector
Total cash
$8.6M
$2.6M
Short term investments
--
$217K
Total assets
$452.9M
$16.7M
Long term debt
$1.5M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
